Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Dynamin 1 anticorps (AA 616-667) (DyLight 550)

Cet anticorps Lapin Polyclonal détecte spécifiquement Dynamin 1 dans FACS. Il présente une réactivité envers Humain.
N° du produit ABIN7354731

Aperçu rapide pour Dynamin 1 anticorps (AA 616-667) (DyLight 550) (ABIN7354731)

Antigène

Voir toutes Dynamin 1 (DNM1) Anticorps
Dynamin 1 (DNM1)

Reactivité

  • 98
  • 42
  • 40
  • 11
  • 9
  • 9
  • 3
  • 2
  • 2
  • 2
  • 1
Humain

Hôte

  • 87
  • 10
  • 4
Lapin

Clonalité

  • 96
  • 6
Polyclonal

Conjugué

  • 48
  • 5
  • 5
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp Dynamin 1 est conjugé à/à la DyLight 550

Application

  • 87
  • 39
  • 39
  • 32
  • 23
  • 13
  • 12
  • 7
  • 7
  • 4
  • 2
  • 1
  • 1
Flow Cytometry (FACS)
  • Épitope

    • 30
    • 22
    • 15
    • 5
    • 4
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 616-667

    Fonction

    Anti-Human Dynamin 1 DyLight® 550 conjugated DNM1 Antibody

    Réactivité croisée (Details)

    No cross-reactivity with other proteins.

    Attributs du produit

    Anti-Human Dynamin 1 DyLight® 550 conjugated DNM1 Antibody -Dyl550. Tested in Flow Cytometry applications. This antibody reacts with Human.

    Purification

    Immunogen affinity purified.

    Immunogène

    E. coli-derived human Dynamin 1 recombinant protein (Position: W616-D667).

    Isotype

    IgG
  • Indications d'application

    Flow Cytometry (Fixed), 1-3 μg/1x106 cells1. Dhindsa, R. S., Bradrick, S. S., Yao, X., Heinzen, E. L., Petrovski, S., Krueger, B. J., Johnson, M. R., Frankel, W. N., Petrou, S., Boumil, R. M., Goldstein, D. B. Epileptic encephalopathy-causing mutations in DNM1 impair synaptic vesicle endocytosis. Neurol. Genet. 1: e4, 2015. 2. EuroEPINOMICS-RES Consortium, Epilepsy Phenome/Genome Project, Epi4K Consortium. De novo mutations in synaptic transmission genes including DNM1 cause epileptic encephalopathies. Am. J. Hum. Genet. 95: 360-370, 2014.

    Commentaires

    Other applications have not been tested. Optimal dilutions should be determined by end users.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    Lot specific

    Buffer

    Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4, 0.02 % Sodium azide.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    -20 °C

    Stockage commentaire

    At -20°C for one year from date of receipt. Avoid repeated freezing and thawing. Protect from light.
  • Antigène

    Dynamin 1 (DNM1)

    Autre désignation

    DNM1

    Sujet

    Synonyms: Dynamin-1, DNM1, DNM

    Background: Dynamin-1 is a protein that in humans is encoded by the DNM1 gene. This gene encodes a member of the dynamin subfamily of GTP-binding proteins. The encoded protein possesses unique mechanochemical properties used to tubulate and sever membranes, and is involved in clathrin-mediated endocytosis and other vesicular trafficking processes. Actin and other cytoskeletal proteins act as binding partners for the encoded protein, which can also self-assemble leading to stimulation of GTPase activity. More than sixty highly conserved copies of the 3' region of this gene are found elsewhere in the genome, particularly on chromosomes Y and 15. Alternatively spliced transcript variants encoding different isoforms have been described.

    Poids moléculaire

    39 kDa

    ID gène

    1759

    UniProt

    Q05193

    Pathways

    Toll-Like Receptors Cascades, CXCR4-mediated Signaling Events, Thromboxane A2 Receptor Signaling
Vous êtes ici:
Chat with us!